D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.76% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Blink Charging
BLNK
$75.2M
| $379K | ﹤0.01% |
+111,766
| New | +$349K |
|
3502
Ooma
OOMA
$550M
| $379K | ﹤0.01% |
35,305
-5,778
| -14% | -$65.6K |
|
3503
Rocky Brands
RCKY
$304M
| $378K | ﹤0.01% |
+12,536
| New | +$277K |
|
|
NXDR
3504
Nextdoor Holdings
NXDR
$835M
| $378K | ﹤0.01% |
199,859
+18,983
| +10% | +$33.5K |
|
3505
Alpha and Omega Semiconductor
AOSL
$923M
| $378K | ﹤0.01% |
+14,489
| New | +$358K |
|
3506
Eve Holding Inc Warrants
EVEX.WS
$45.1M
| $377K | ﹤0.01% |
384,473
+63,593
| +20% | +$44.9K |
|
3507
Royalty Pharma
RPRX
$26.1B
| $376K | ﹤0.01% |
13,387
-384,459
| -97% | -$10.6M |
|
3508
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
| $376K | ﹤0.01% |
+4,819
| New | +$360K |
|
|
RNAM
3509
DELISTED
Avidity Biosciences
RNAM
| $375K | ﹤0.01% |
41,486
-111,793
| -73% | -$747K |
|
3510
Horizon Technology Finance
HRZN
$294M
| $375K | ﹤0.01% |
+28,461
| New | +$348K |
|
3511
Ameresco
AMRC
$1.15B
| $375K | ﹤0.01% |
+11,835
| New | +$357K |
|
|
ICVX
3512
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $374K | ﹤0.01% |
+23,715
| New | +$228K |
|
3513
Skyworks Solutions
SWKS
$9.06B
| $371K | ﹤0.01% |
3,300
-47,819
| -94% | -$4.68M |
|
|
CFB
3514
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $369K | ﹤0.01% |
27,152
+10,545
| +63% | +$121K |
|
|
HA
3515
DELISTED
Hawaiian Holdings, Inc.
HA
| $368K | ﹤0.01% |
25,937
-35
| -0.1% | -$260 |
|
3516
PTC
PTC
$13.7B
| $365K | ﹤0.01% |
2,086
-4,522
| -68% | -$694K |
|
3517
CDW
CDW
$17.1B
| $364K | ﹤0.01% |
1,600
-2,941
| -65% | -$623K |
|
3518
RPC Inc
RES
$1.24B
| $363K | ﹤0.01% |
49,917
-173,161
| -78% | -$1.36M |
|
3519
Banco de Chile
BCH
$20.6B
| $362K | ﹤0.01% |
15,682
+5,035
| +47% | +$107K |
|
3520
Saratoga Investment
SAR
$309M
| $362K | ﹤0.01% |
+13,996
| New | +$350K |
|
|
LILM
3521
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $362K | ﹤0.01% |
306,679
+24,349
| +9% | +$22.2K |
|
3522
Oppenheimer Holdings
OPY
$1.17B
| $360K | ﹤0.01% |
+8,705
| New | +$333K |
|
3523
Evercore
EVR
$13.1B
| $360K | ﹤0.01% |
2,102
+602
| +40% | +$87.2K |
|
|
GOOS
3524
Canada Goose Holdings
GOOS
$868M
| $359K | ﹤0.01% |
30,262
-103,849
| -77% | -$1.23M |
|
|
MAXN
3525
PUT
DELISTED
Maxeon Solar Technologies
MAXN
| $359K | ﹤0.01% |
+501
| New | +$327K |
|
Similar funds
D.E. Shaw & Co's Q4 2023 Portfolio in Review
As of Q4 2023, D.E. Shaw & Co held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- D.E. Shaw & Co added most to Netflix in Q4 2023, an estimated $751M increase.
- D.E. Shaw & Co's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- D.E. Shaw & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- D.E. Shaw & Co opened 575 new positions and closed 527 in Q4 2023.
- D.E. Shaw & Co's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.